Loading...
XHKG
1666
Market cap776mUSD
Dec 05, Last price  
4.72HKD
1D
0.21%
1Q
-3.87%
Jan 2017
-67.18%
IPO
608.00%
Name

Tong Ren Tang Technologies Co.

Chart & Performance

D1W1MN
XHKG:1666 chart
P/E
10.52
P/S
0.76
EPS
0.41
Div Yield, %
4.19%
Shrs. gr., 5y
Rev. gr., 5y
10.15%
Revenues
7.26b
+7.18%
1,135,678,0001,034,768,0001,157,030,0001,211,455,0001,307,897,0001,578,914,0001,936,418,0002,447,132,0002,910,749,0003,341,166,0004,066,960,0004,665,295,0005,025,183,0005,059,638,0004,476,449,0004,607,369,0005,400,487,0005,991,841,0006,773,463,0007,259,644,000
Net income
522m
-11.59%
231,186,000143,456,000153,520,000160,528,000173,027,000198,342,000254,687,000330,171,000390,093,000462,187,000540,481,000595,654,000666,666,000677,815,000417,650,000467,553,000507,249,000582,888,000590,188,000521,795,000
CFO
16m
-97.18%
164,654,000127,391,000-42,264,000115,851,000231,293,000266,837,000255,830,000401,648,000375,451,000333,875,000303,843,000410,005,000679,807,000985,236,0001,051,775,000435,810,0001,033,415,000723,769,000554,175,00015,607,000
Dividend
Jun 14, 20240.19776 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and Hong Kong. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services. In addition, it is involved in the technological development and sale of biological products, Chinese and Western medicines, cosmetics, and healthcare products; wholesale and retail sale of Chinese medicines and healthcare products; and internal and external surgery, medical examination, and hospital management activities. Further, it produces and processes biochemical products; extracts and processes plants; and produces food and daily chemical products, and medical services. The company was founded in 1669 and is based in Beijing, the People's Republic of China.
IPO date
Oct 31, 2000
Employees
4,030
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT